Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Synta to Host Conference Call and Webcast of First Quarter 2013 Financial Results on April 30, 2013

  Synta to Host Conference Call and Webcast of First Quarter 2013 Financial
  Results on April 30, 2013

Business Wire

LEXINGTON, Mass. -- April 16, 2013

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will
release its first quarter 2013 financial results before the market opens on
Tuesday, April 30, 2013.

Following the issuance of the press release, management will conduct a
conference call at 10:00 a.m. (EDT) that morning to review the Company's first
quarter financial results. The conference call will be webcast live over the
Internet and can be accessed by logging on to the "Investors" section of the
Synta Pharmaceuticals website,, prior to the event.

The call can also be accessed by dialing (877) 407-8035 or (201) 689-8035
prior to the start of the call. For those unable to join the live conference
call, a replay will be available from 2:00 p.m. (EDT) on April 30 through
midnight (EDT) on May 7. To access the replay, dial (877) 660-6853 or (201)
612-7415 and refer to conference ID 412350. The webcast will also be archived
on the Company's website.

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to extend
and enhance the lives of patients with severe medical conditions, including
cancer and chronic inflammatory diseases. Synta has a unique chemical compound
library, an integrated discovery engine, and a diverse pipeline of clinical-
and preclinical-stage drug candidates with distinct mechanisms of action and
novel chemical structures. All Synta drug candidates were invented by Synta
scientists using our compound library and discovery capabilities. For more
information, please visit


Synta Pharmaceuticals Corp.
George Farmer, 781-541-7213
Sponsored Links
Sponsored Links